标题
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2022-02-08
DOI
10.1080/21645515.2021.2002083
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Narrative Review on Characterization of Acute Respiratory Distress Syndrome in COVID-19-infected Lungs using Artificial Intelligence
- (2021) Jasjit S. Suri et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
- (2021) Mark J. Mulligan et al. NATURE
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report
- (2021) Kai Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
- (2021) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
- (2021) Eric Yuk Fai Wan et al. LANCET INFECTIOUS DISEASES
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
- (2021) Hannah G. Rosenblum et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
- (2021) Patrick Tang et al. NATURE MEDICINE
- Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
- (2020) Daniela Calina et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: Johnson and Johnson vaccine trial is paused because of unexplained illness in participant
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
- (2020) Lene H. Garvey et al. BRITISH JOURNAL OF ANAESTHESIA
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started